Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

Subjects:

Changes in the UACR and urinary β2-MG levels compared with baseline values over time. by Jia Song (495396)

Subjects:

Changes in the eGFRs and serum potassium levels compared with baseline values in all patients over time. by Jia Song (495396)

Subjects:

Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups. by Jia Song (495396)

Subjects:

Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time. by Jia Song (495396)

Subjects:

Changes in inflammatory cytokine levels compared with baseline values in all patients over time. by Jia Song (495396)

Subjects:

Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

Subjects:

Baseline characteristics of the participants. by Jia Song (495396)

Subjects:

Phosphatidylcholine (PC) decreases the nuclear c-Fos and c-Jun protein levels under lipopolysaccharide (LPS) stimulation in MG6 cells. by Sachiko Mizuno (21799645)

NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. by Jinwei Zhang (462455)

“…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …”

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Effects of GJE extract treatment decreased protein expression of MMP-12, α-SMA, IL-13, and TGF-β1 levels. by Natnicha Suttawong (22367172)

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection. by Jeffrey Chin (22538086)

Diagrammatic illustration showing the time-course of the experimental set-up as well as the experimental endpoints. by Bryan S. Margulies (21492667)

Subjects:

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. by Siyu Yuan (7425719)

Subjects:

UpSet plot summarising key differentially expressed gene trends and Gene ontology analysis of differentially expressed genes present only in extremely high viral load group. by Vasanthi Avadhanula (259546)

Subjects:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …”